The FDA has proposed removing the boxed warning for menopausal hormone therapy, focusing on local estrogen use and ...

Controversy and confusion have shrouded hormone replacement therapy (HRT)—which involves using estrogen to help alleviate ...

Menopause, the natural cessation of periods due to lower hormone levels, typically occurs between the ages of 45 and 55. The ...

A growing body of research suggests testosterone replacement therapy can alleviate menopausal symptoms such as a decrease in ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to ...

The hormonal replacement therapy market size is calculated at USD 25.88 billion in 2025 and is expected to reach around USD 46.32 billion by 2034, growing at a CAGR of 6.68% for the forecasted period.

Hormonal changes during menopause can lead to dry eye disease, making eyes feel irritated, watery, or blurry - a hidden ...

The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer ...

The Atlantic Menopause Show brings women together to hear the latest research on mood changes and brain fog, hormone therapy ...

Melbourne researchers have discovered gender-affirming hormone therapy can alter body proteins to match a person's gender ...

Melbourne researchers have discovered gender-affirming hormone therapy can alter body proteins to match a person's gender ...